BCM
PFE icon

Blume Capital Management’s Pfizer PFE Stock Holding History

Blume Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.81M Buy
241,130
+3,035
+1% +$79.4K 0.85% 37
2026
Q1 		$6.69M Buy
238,095
+9,790
+4% +$261K 1.14% 30
2025
Q4 		$5.68M Buy
228,305
+1,684
+0.7% +$42.5K 1.03% 33
2025
Q3 		$5.77M Buy
226,621
+32,088
+16% +$792K 1.1% 37
2025
Q2 		$4.72M Buy
194,533
+5,900
+3% +$138K 0.95% 40
2025
Q1 		$4.78M Buy
188,633
+71,075
+60% +$1.86M 1.07% 38
2024
Q4 		$3.12M Buy
117,558
+18,249
+18% +$495K 0.7% 46
2024
Q3 		$2.87M Buy
99,309
+24,321
+32% +$709K 0.64% 47
2024
Q2 		$2.1M Buy
74,988
+9,195
+14% +$253K 0.51% 48
2024
Q1 		$1.83M Buy
65,793
+16,568
+34% +$460K 0.44% 49
2023
Q4 		$1.42M Buy
49,225
+23,000
+88% +$695K 0.37% 52
2023
Q3 		$870K Buy
26,225
+14,840
+130% +$525K 0.26% 60
2023
Q2 		$418K Buy
11,385
+8,740
+330% +$340K 0.12% 65
2023
Q1 		$108K Hold
2,645
– – 0.03% 123
2022
Q4 		$136K Sell
2,645
-75
-3% -$3.6K 0.05% 109
2022
Q3 		$119K Sell
2,720
-30
-1% -$1.46K 0.04% 105
2022
Q2 		$144K Sell
2,750
-675
-20% -$34.4K 0.06% 97
2022
Q1 		$177K Sell
3,425
-86,380
-96% -$4.48M 0.06% 90
2021
Q4 		$5.3M Sell
89,805
-27,480
-23% -$1.36M 1.75% 22
2021
Q3 		$5.04M Sell
117,285
-5,227
-4% -$232K 1.85% 19
2021
Q2 		$4.8M Buy
122,512
+36,098
+42% +$1.4M 1.75% 21
2021
Q1 		$3.13M Buy
86,414
+80,140
+1,277% +$2.85M 1.23% 28
2020
Q4 		$231K Sell
6,274
-339
-5% -$12.4K 0.1% 64
2020
Q3 		$230K Hold
6,613
– – 0.12% 56
2020
Q2 		$205K Hold
6,613
– – 0.11% 57
2020
Q1 		$204K Hold
6,613
– – 0.13% 54
2019
Q4 		$245K Hold
6,613
– – 0.12% 59
2019
Q3 		$225K Hold
6,613
– – 0.11% 62
2019
Q2 		$272K Hold
6,613
– – 0.14% 58
2019
Q1 		$266K Hold
6,613
– – 0.14% 59
2018
Q4 		$274K Hold
6,613
– – 0.16% 63
2018
Q3 		$276K Hold
6,613
– – 0.14% 53
2018
Q2 		$228K Hold
6,613
– – 0.12% 57
2018
Q1 		$222K Sell
6,613
-105
-2% -$3.61K 0.12% 56
2017
Q4 		$231K Hold
6,718
– – 0.12% 59
2017
Q3 		$228K Hold
6,718
– – 0.12% 57
2017
Q2 		$214K Hold
6,718
– – 0.12% 54
2017
Q1 		$218K Hold
6,718
– – 0.13% 54
2016
Q4 		$207K Sell
6,718
-559
-8% -$17.1K 0.12% 54
2016
Q3 		$234K Hold
7,277
– – 0.14% 51
2016
Q2 		$243K Buy
7,277
+559
+8% +$17.8K 0.16% 51
2016
Q1 		$189K Hold
6,718
– – 0.13% 55
2015
Q4 		$206K Sell
6,718
-2,846
-30% -$89.5K 0.15% 56
2015
Q3 		$285K Sell
9,564
-3,021
-24% -$96.9K 0.23% 40
2015
Q2 		$400K Sell
12,585
-1,130
-8% -$36.8K 0.3% 38
2015
Q1 		$453K Sell
13,715
-1,897
-12% -$60.3K 0.31% 38
2014
Q4 		$461K Buy
15,612
+9,464
+154% +$271K 0.32% 39
2014
Q3 		$172K Hold
6,148
– – 0.13% 49
2014
Q2 		$173K Hold
6,148
– – 0.14% 51
2014
Q1 		$187K Hold
6,148
– – 0.15% 49
2013
Q4 		$179K Buy
+6,148
New +$179K 0.15% 49

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Blume Capital Management's PFE Position: Q2 2026 in Review

Blume Capital Management increased its Pfizer (PFE) stake by 1.3% in Q2 2026, buying an estimated $79.4K and bringing the position to 241,130 shares worth $5.81M. The position accounts for 0.85% of the portfolio, ranked #37.

Blume Capital Management first reported a position in PFE in Q4 2013 and has held it in 51 quarters since. The position peaked at $6.69M in Q1 2026. 1,328 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Blume Capital Management held 241,130 shares of Pfizer worth $5.81M as of Q2 2026.
  • Blume Capital Management bought 3,035 Pfizer shares in Q2 2026, an estimated $79.4K.
  • Pfizer made up 0.85% of Blume Capital Management's portfolio in Q2 2026, its #37 holding.
  • Blume Capital Management first reported a position in Pfizer in Q4 2013 and has held it in 51 quarters since.
  • Blume Capital Management's Pfizer position peaked at $6.69M in Q1 2026.
  • 1,328 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.